Mergers and Acquisitions

The time has come! The first live events are starting again, including Vitafoods in Geneva. Unlike usual, Vitafoods is a hybrid event. Participants can decide if they want to participate online only or visit the halls in Geneva as well. Have a look at the booth pictures of some of our partners in…
Read More...

As compared to the previous months, September was a slower month for dealmaking. The Wall Street Journal recently attributed the drought in big biotech deals to the riskiness of the business. In a note to clients, a Jefferies health care trader wrote: “What appears to be a best-in-class drug on a…
Read More...

16. September 2018 In August, the biotech boom of 2018 continued unabated and the Wall Street Journal reported that investment banks have lured top biotech analysts with guaranteed pay packages of USD 3 million or more. At this time of the year, equity analysts who assess companies and write…
Read More...

18. June 2018 Top Pharma & Biotech Deals, Investments and M&As in May 2018 As April 2018 breezed past with news of Novartis’ US$ 8.7 billion buyout of AveXis, May set the temperatures soaring with one of the largest pharma acquisitions in recent years. Japanese…
Read More...